Real-time enrollment status for this opioid-induced respiratory depression clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 1:09 PM UTC
| NCT Number | NCT07573150 |
| Recruiting Status | Recruiting |
| Condition | Opioid-Induced Respiratory Depression |
| Phase | Clinical Trial |
| Target Enrollment | 300 participants |
| Active Locations | 2 sites in the US |
| Sponsor | NeurOptics Inc |
| Last Updated on CT.gov | May 8, 2026 (May 8, 2026) |
As of July 13, 2026: Clinical trial NCT07573150 is currently recruiting participants. This clinical trial study for opioid-induced respiratory depression is actively seeking new participants at 2 locations across the United States. The study is sponsored by NeurOptics Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07573150 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07573150 was last updated May 8, 2026 (May 8, 2026). HelloStudys verifies this status automatically.